Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trialGuy Thwaites, Elian Liu, Matthew Scarborough et al.|The Lancet|2017Cited by 186
Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definitionPatrick N. A. Harris, David L. Paterson, Leonard Leibovici et al.|Clinical Microbiology and Infection|2016Cited by 83
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trialGuy Thwaites, A. Sarah Walker, Cressida Auckland et al.|Trials|2012Cited by 27
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCTGuy Thwaites, A. Sarah Walker, Matthew Scarborough et al.|Health Technology Assessment|2018Cited by 15
Procalcitonin testing combined with NEWS2 evaluation compared with usual care based on NEWS2 for identification of sepsis and antibiotic initiation in the emergency department in England and Wales (PRONTO): a multicentre, randomised, controlled, open-label, phase 3 trialStacy Todd, Joanne Euden, Jennifer Condie et al.|The Lancet Respiratory Medicine|2026Cited by 1